Early diagnosis improves survival in colorectal cancer

Practitioner

Volumn 256, Issue 1753, 2012, Pages 15-18

  Keane, Margaret G ^a   Johnson, Gavin J ^b  

^a Academic Clinical Fellow in Gastroenterology and Hepatology   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLONOSCOPY; COLORECTAL TUMOR; CONFERENCE PAPER; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; METHODOLOGY; MORTALITY; OCCULT BLOOD; PATIENT REFERRAL;

COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; OCCULT BLOOD; REFERRAL AND CONSULTATION;

EID: 84865328573     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18(3):581-592 (Pubitemid 46359643)
2. http://info.cancerresearchuk.org/cancerstats/types/bowel/incidence/ uk-bowel-cancer-incidence-statistics
3. Thomson CS, Forman D. Cancer survival in England and the influence of early diagnosis: What can we learn from recent EUROCARE results? Br J Cancer2009;101(suppl 2):S102-4
4. Thompson MR, Perera R, Senapati A, Dodds S. Predictive value of common symptom combinations in diagnosing colorectal cancer. Br J Surg2007;94:1260-1265 (Pubitemid 47584776)
5. Shallow TA, Wagner FB, Colcher RE. Clinical evaluation of 750 patients with colon cancer. Diagnostic survey and followup covering a 15 year period. Ann Surg1955;142: 164-175
6. Flashman K, O'Leary DP, Senapati A, Thompson MR. The Department of Health's "Two-week standard" for bowel cancer: Is it working? Gut2004:53(3):387-391 (Pubitemid 38241336)
7. Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology. BMJ2000;321 (7264):805-8
8. Bergstrom A, Pisani P, Tenet V et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer2001; 91:421-430 (Pubitemid 32049639)
9. Samad AK, Taylor RS, Marshall T, Chapman MA. A meta-analysis of the association of physical activity with reduced risk of colorectal cancer. Colorectal Diseases 2005;7:204-213 (Pubitemid 40637417)
10. Steinmetz KA, Potter JD. Vegetables, fruit and cancer prevention: A review. J Am Diet Assoc1996; 96:1027-1039 (Pubitemid 27382158)
11. Bingham SA, Day NE, Luben R et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and utrition (EPIC): An observational study. Lancet 2003; 361:1496-1501 (Pubitemid 36566339)
12. Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: Dose-response meta-analysis of epidemiological studies. Int J Cancer 2002; 98:241-256 (Pubitemid 34150809)
13. Faivre J, Bouvier A-M, Bonithon-Kopp C. Epidemiology and screening of colorectal cancer. Best Practice & Research Clinical Gastroenterology2002; 16:187-199
14. Cairns SR, Scholefield JH, Steele RJ et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).Gut 2010;59: 666-690
15. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ2004; 329:133
16. NHS Bowel Cancer Screening Programme. 2009. www.cancerscreening.nhs.uk/ bowel/publications/nhsbcsp-guidance-note-1.pdf
17. Atkin WA, Edwards R, Kralj-Hans I et al. UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial. Lancet 2010;375:1624 -1633
18. Atkin WS, Saunders BP. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002; 51(Suppl V):v6-v9 (Pubitemid 35222897)
19. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med1993; 328(19):1365-71 (Pubitemid 23131388)
20. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996. 348: 1472-7 (Pubitemid 26400242)
21. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecaloccult- blood test. Lancet 1996; 348(9040): 1467-71 (Pubitemid 26400241)
22. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer Br J Surg2008; 95:1029-1036
23. Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer.Cancer Invest 2005;23(4):338-51 (Pubitemid 41656973)
24. Wilson JMG, Jungner G. Principles and practice of screening for disease. WHO Chronicle1968; 22: 473
25. Irvine T, Scott M, Clark CI. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer. Colorectal Dis 2007; 9(6):527-31 (Pubitemid 46958543)
26. Wiratkapun S, Kraemer M, Seow-Choen F et al. High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: Results of a five year study. Dis ColonRectum 2001; 44:231-5 (Pubitemid 32173772)
27. Pignone M, Rich M, Teutsch SM et al. Screening for colorectal cancer in adults at average risk: A summary of the evidence for the US Preventive Services Task Force. Ann Intern Med2002;137(2):132-141 (Pubitemid 34779159)
28. Gavin D, Valori R, Anderson J et al. OC-007 The national colonoscopy audit: A nationwide assessment of the quality and safety of colonoscopy in the UK. Gut 2012;61:A3
29. http://info.cancerresearchuk.org/cancerstats/types/bowel/incidence/
30. National Institute for Health and Clinical Excellence.
31. Improving standards in colorectal cancer. NICE. London. 2004
32. Hippisley-Cox J, Coupland C. Identifying patients with suspected colorectal cancer in primary care: Derivation and validation of an algorithm. Br J Gen Pract2012; 62(594): E29-37
33. http://info.cancerresearchuk.org/cancerstats/types/bowel/survival/ bowel-cancer-survival-statistics
34. National Institute for Health and Clinical Excellence CG131. Colorectal cancer: The diagnosis and management of colorectal cancer. NICE. London. 2011
35. National Institute for Health and Clinical Excellence. TA61. Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer. NICE. London. 2003
36. Van Hooft JE, Bemelman WA, Oldenburg B et al. Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: A multicentre randomised trial. Lancet Oncol 2011;12:344-52
37. Hanks H, Veitch C, Harris M. Colorectal cancer management - the role of the GP. Aust Fam Physician 2008; 37(4):259-61